Mga Batayang Estadistika
| CIK | 1792030 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to IM Cannabis Corp.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| September 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4 (Address of |
|
| September 5, 2025 |
IM Cannabis Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement Exhibit 99.1 IM Cannabis Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement TORONTO and GLIL YAM, Israel, September 5, 2025/CNW/ - IM Cannabis Corp. (NASDAQ: IMCC) (the “Company”, “IM Cannabis”, or “IMC”), a leading medical cannabis company with operations in Israel and Germany, today announced that it received notice from Nasdaq on September 4, 2025 that the Company has regai |
|
| August 25, 2025 |
As filed with the Securities and Exchange Commission on August 25, 2025 As filed with the Securities and Exchange Commission on August 25, 2025 Registration No. |
|
| August 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 (Report No. 3). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of |
|
| August 13, 2025 |
COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 4.4 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE MARCH 13, 2025. THE WARRANTS EVIDENCED HEREBY ARE EXERCISABLE AT OR BEFORE 4:00 P.M. (TORONTO TIME) ON NOVEMBER 12, 2026, AFTER WHICH TIME THE WARRANTS EVIDENCED HEREBY SHALL BE DEEMED TO BE V |
|
| August 13, 2025 |
As filed with the Securities and Exchange Commission on August 13, 2025 As filed with the Securities and Exchange Commission on August 13, 2025 Registration No. |
|
| August 13, 2025 |
Calculation of Filing Fee Tables F-3 IM Cannabis Corp. Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial E |
|
| August 13, 2025 |
IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing Exhibit 99.3 IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing Toronto, Ontario and Glil Yam, Israel – August 13, 2025 – IM Cannabis Corp. (“IM Cannabis” or the “Company”) (NASDAQ: IMCC), a leading medical cannabis company with operations in Israel and Germany, announces that it has agreed with holders (each, a “Holder”) of common share purchase warrants (“ |
|
| August 13, 2025 |
AMENDMENT NO. 1 TO COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 4.5 AMENDMENT NO. 1 TO COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. This Amendment No. 1 to the Common Share Purchase Warrant (this “Amendment”) dated this [] day of August 2025, by and among IM Cannabis Corp., a British Columbia corporation (the “Company”) and [] (the “Holder”). WHEREAS, the Holder holds outstanding warrants to purchase up to (i) [] common shares, no par value per shar |
|
| August 13, 2025 |
COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 4.1 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE DECEMBER 1, 2025. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE |
|
| August 12, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Uri Birenberg, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “Interim Filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended June 30, 2025. 2. No misrepresentations: Based on my knowled |
|
| August 12, 2025 |
Exhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 7 GEOGRAPHIES AND NEW MARKETS 7 BRANDS 8 NEW PRODUCT OFFERINGS 10 HIGH-QUALITY, RELIABLE SUPPLY 10 CORPORATE HIGHLIGHTS AND EVENTS 11 REVIEW OF FINANCIAL PERFORMANCE 19 LEGAL AND REGULATORY 58 RISK FACTORS 67 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 75 2 Management’s Discussion an |
|
| August 12, 2025 |
IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2025 Exhibit 99.2 IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2025 (Unaudited) IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2025 Canadian dollars in thousands (Unaudited) INDEX Page Interim Condensed Consolidated Statements of Financial Position F-2 - F-3 Interim Condensed Consolidated Statements of Operations and Other Co |
|
| August 12, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended June 30, 2025. 2. No misrepresentations: Based on my knowle |
|
| August 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| August 12, 2025 |
IM Cannabis Reports Second Quarter 2025 Financial Results Exhibit 99.1 IM Cannabis Reports Second Quarter 2025 Financial Results IMC Delivers Strong Profit and Margin Growth Despite Revenue Impact from External Challenges in Q2 2025 TORONTO and GLIL YAM, Israel, August 12, 2025 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the second quarter e |
|
| August 4, 2025 |
IM Cannabis to Report Second Quarter 2025 Financial Results on Tuesday, August 12th at 9:00am ET Exhibit 99.1 IM Cannabis to Report Second Quarter 2025 Financial Results on Tuesday, August 12th at 9:00am ET TORONTO and GLIL YAM, Israel, August 4, 2025/CNW/ - IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter 2025 ended June 30, 2 |
|
| August 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| July 31, 2025 |
IM CANNABIS CORP. Subscription Agreement for Units Exhibit 99.2 CANADA/UNITED STATES/OFFSHORE THE SECURITIES BEING SUBSCRIBED FOR HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”), OR UNDER ANY OTHER APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS DEFINED HEREIN) UNLESS SUCH SECURITIES ARE REGISTERE |
|
| July 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 (Report No. 4). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of p |
|
| July 31, 2025 |
PRE-FUNDED COMMON SHARE PURCHASE WARRANT Exhibit 99.4 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE DECEMBER 1, 2025. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (TH |
|
| July 31, 2025 |
COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 99.6 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE , 2025. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SE |
|
| July 31, 2025 |
IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million Exhibit 99.7 IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million Toronto, Ontario and Glil Yam, Israel – July 31, 2025 – IM Cannabis Corp. (“IM Cannabis” or the “Company”) (NASDAQ: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, effective July 30, 2025 (the “Closing Date”) it has closed a private plac |
|
| July 31, 2025 |
Exhibit 99.5 ADVISORY AGREEMENT This Consulting Agreement (the “Agreement”) is entered into and made effective as of the 31 day of July, 2025, BY AND BETWEEN: Pure Equity Ltd., a private company duly incorporated under the laws of the State of Israel, having its registered office at 20 Raul Wallenberg Street, Ramat Hachayal, Tel Aviv, Israel, Company No. 516006418 (hereinafter referred to as the “ |
|
| July 31, 2025 |
COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 99.3 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE DECEMBER 1, 2025. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (TH |
|
| July 31, 2025 |
IM CANNABIS CORP. Subscription Agreement for Units Exhibit 99.1 CANADA/UNITED STATES/OFFSHORE THE SECURITIES BEING SUBSCRIBED FOR HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”), OR UNDER ANY OTHER APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS DEFINED HEREIN) UNLESS SUCH SECURITIES ARE REGISTERE |
|
| July 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 (Report No. 3). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of p |
|
| July 11, 2025 |
IM CANNABIS ANNOUNCES FILING OF SHELF REGISTRATION STATEMENT ON FORM F-3 Exhibit 99.1 IM CANNABIS ANNOUNCES FILING OF SHELF REGISTRATION STATEMENT ON FORM F-3 TORONTO and GLIL YAM, Israel, July 11, 2025 - IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce the filing and effectiveness of a shelf registration statement (the “Shelf Registration”) on Form F-3 with the S |
|
| July 9, 2025 |
Exhibit 10.1 Loan Agreement Made and signed on the 6 day of July, 2025 BETWEEN: L.I.A. PURE CAPITAL LTD Company Number: 514408715 (Hereinafter each referred to as a 'Lender', and collectively, the 'Lenders') - On the one part - AND: IM Cannabis Corp. Company Number: 205955 (Hereinafter referred to as the 'Borrower' and/or the 'Company') - On the other part - Whereas the Borrower is a public compan |
|
| July 9, 2025 |
Exhibit 99.1 IM Cannabis Announces the Signing of a Loan Agreement and Appointment of Oz Adler to Board of Directors TORONTO and GLIL YAM, Israel, July 9, 2025 - IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Mr. Oz Adler has been appointed to the Company’s board of directors (the “Boa |
|
| July 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 (Report No. 2). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of p |
|
| July 7, 2025 |
IM Cannabis Corp. Beit Hakshatot, Kibutz Glil-Yam 4690500, Israel IM Cannabis Corp. Beit Hakshatot, Kibutz Glil-Yam 4690500, Israel July 7, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 RE: IM Cannabis Corp. (CIK: 0001792030) Registration Statement No. 333-288346 on Form F-3 (the “Registration Statement”) Request for Acceleration of Effect |
|
| July 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4 (Address of princ |
|
| July 1, 2025 |
IM Cannabis Provides Corporate Updates Exhibit 99.1 IM Cannabis Provides Corporate Updates TORONTO and GLIL YAM, Israel, July 1, 2025/CNW/ - IM Cannabis Corp. (NASDAQ: IMCC) (the “Company”, “IM Cannabis”, or “IMC”), a leading medical cannabis company with operations in Israel and Germany, today announced the following corproate updates. As previously reported on April 11, 2025, the Company received a deficiency letter (the “Nasdaq Lett |
|
| June 26, 2025 |
As filed with the Securities and Exchange Commission on June 26, 2025 As filed with the Securities and Exchange Commission on June 26, 2025 Registration No. |
|
| June 26, 2025 |
Exhibit 107 Calculation of Filing Fee Tables FORM F-3 (Form Type) IM CANNABIS CORP. |
|
| May 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 28, 2025 |
IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange Exhibit 99.1 IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange TORONTO and GLIL YAM, Israel, May 28, 2025 /CNW/ - IM Cannabis Corp. (the “Company” or “IMC”) (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announces that it has applied for a voluntary delisting of its common shares (“Shares”) from the Canadian Securities Exchange (the “CS |
|
| May 27, 2025 |
DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Exhibit 99.1 THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES IM Cannabis Provides Corporate Updates Toronto, Ontario and Glil Yam, Israel – May 27, 2025 – IM Cannabis Corp. (“IM Cannabis” or the “Company”) (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with op |
|
| May 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 15, 2025 |
Exhibit 99.2 IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of March 31, 2025 Canadian dollars in thousands (Unaudited) INDEX Page Interim Condensed Consolidated Statements of Financial Position 2 - 3 Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income 4 - 5 Interim Condensed Consolidated Statements of Changes in Equity 6 Interim Con |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 15, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Uri Birenberg, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended March 31, 2025. 2. No misrepresentations: Based on my knowle |
|
| May 15, 2025 |
Exhibit 99.1 IM CANNABIS CORP. IM Cannabis Reports First Quarter Financial Results IMC Delivers Net Profit and 87% Gross Margin Improvement in Q1, Reflecting Strategic and Operational Progress. TORONTO, and GLIL YAM, Israel, May 15, 2025 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results t |
|
| May 15, 2025 |
Eexhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 5 STRATEGY IN DETAIL 7 GEOGRAPHIES AND NEW MARKETS 7 BRANDS 8 NEW PRODUCT OFFERINGS 10 HIGH-QUALITY, RELIABLE SUPPLY 10 CORPORATE HIGHLIGHTS AND EVENTS 11 REVIEW OF FINANCIAL PERFORMANCE 17 LEGAL AND REGULATORY 52 RISK FACTORS 62 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 69 2 Management’s Discussion a |
|
| May 15, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended March 31, 2025. 2. No misrepresentations: Based on my knowl |
|
| May 7, 2025 |
Exhibit 99.1 IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction TORONTO and GLIL YAM, Israel, May 7, 2025/CNW/ - IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) (the “Company” or “IM Cannabis”), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executiv |
|
| May 6, 2025 |
IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15 Exhibit 99.1 IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET TORONTO and GLIL YAM, Israel, May 6, 2025 - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2025 ended March 31, |
|
| May 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 5, 2025 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 04/30/2025: 3,085,452 Common Shares. Date: May 5, 2025 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Wher |
|
| May 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| April 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4 (Address of prin |
|
| April 11, 2025 |
IM Cannabis Provides Corporate Updates Exhibit 99.1 IM Cannabis Provides Corporate Updates TORONTO and GLIL YAM, Israel, April 11, 2025/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company”, “IM Cannabis”, or “IMC”), a leading medical cannabis company with operations in Israel and Germany, today announced the following corproate updates. Nasdaq Notification Letter The Company has received a written notification (the “Notif |
|
| April 3, 2025 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 03/31/2025: 3,085,452 Common Shares. Date: April 3, 2025 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Wh |
|
| April 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| March 31, 2025 |
Exhibit 15.4 TABLE OF CONTENTS EXECUTIVE SUMMARY 5 STRATEGY IN DETAIL 7 GEOGRAPHIES AND NEW MARKETS 7 BRANDS 8 NEW PRODUCT OFFERINGS 10 HIGH-QUALITY, RELIABLE SUPPLY 10 CORPORATE HIGHLIGHTS AND EVENTS 11 REVIEW OF FINANCIAL PERFORMANCE 19 LEGAL AND REGULATORY 58 RISK FACTORS 68 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 74 2 Management’s Discussion and Analysis INTRODUCTION IM Cannabis C |
|
| March 31, 2025 |
IM CANNABIS CORP. STOCK TRADING POLICY Exhibit 11.1 IM CANNABIS CORP. STOCK TRADING POLICY IM CANNABIS CORP. STOCK TRADING POLICY 1. Purpose of this Policy The board of directors (the “Board”) of IM Cannabis Corp. (the “Company”) has adopted this Stock Trading Policy (the “Policy”), which is designed to provide guidance to the directors, officers and employees of the Company and its subsidiaries (who are referred to collectively in thi |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT |
|
| March 31, 2025 |
IM CANNABIS CORP. INCENTIVE COMPENSATION RECOVERY POLICY Exhibit 97 IM CANNABIS CORP. INCENTIVE COMPENSATION RECOVERY POLICY 1. Introduction. The Board of Directors of IM Cannabis Corp. (the “Company”) believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company's compensation philosophy. The Board has therefore adopted this pol |
|
| March 31, 2025 |
Exhibit 4.7 Unofficial Translation Loan Agreement and Principles Agreement Executed and Signed on November 29, 2022, in Galil Yam Between: IMC Holdings Ltd. Company No. 515778348 From Beit HaKeshet, Kibbutz Galil Yam, Israel (hereinafter: "the Lender"), On the first part; And: Telecanna Ltd. Company No. 516591781 From 24 A-Sultani Road, Tira, Israel (hereinafter: "the Borrower" or "the Company", a |
|
| March 31, 2025 |
IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results Exhibit 99.1 IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results Q4 2024 Caps a Year of Strategic and Operational Improvements for IMC with 25% Revenue Growth, 42% decrease in Operating Expenses, and $0.5M Adjusted EBITDA Profit. TORONTO, Ontario and GLIL YAM, Israel, March 31, 2025 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an interna |
|
| March 31, 2025 |
Exhibit 4.8 Unofficial Translation Loan Agreement and Principles Agreement Executed and Signed on January 5, 2025 Between: IMC Holdings Ltd. Company No. 515778348 From Beit HaKeshet, Kibbutz Galil Yam, Israel (hereinafter: "the Lender"), On the first part; And: Nidal Almaghrabi, ID No. 021922893 (hereinafter: "the Purchaser") On the second part; (IMC and the Purchaser shall hereinafter be referred |
|
| March 31, 2025 |
Consent of Independent Registered Public Accounting Firm Exhibit 15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form F-10 No. 333-254255) of IM Cannabis Corp. and in the related Prospectus of our report dated March 28, 2024, with respect to the consolidated financial statements of IM Cannabis Corp. included in this Annual Report (Form 20-F) for the year ended Dece |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| March 31, 2025 |
DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT Exhibit 2.1 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT Except as otherwise stated, the information in this Description of Securities is provided as of the date of the Annual Report. The following summary does not purport to be complete. The summary is subject to and qualified by the Articles of IM Cannabis Corp. (“Articles”), which are filed as Exhibit 1.1 to the Ann |
|
| March 31, 2025 |
Consent of Independent Registered Public Accounting Firm Exhibit 15.2 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form F-10 No. 333-254255) of IM Cannabis Corp. and in the related Prospectus of our report dated March 31, 2025, with respect to the consolidated financial statements of IM Cannabis Corp. included in this Annual Report (Form 20-F) for the year ended Dece |
|
| March 31, 2025 |
CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 12.2 CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 I, Uri Birenberg, certify that: 1. I have reviewed this annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the c |
|
| March 31, 2025 |
Exhibit 15.3 March 31, 2025 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read Item 16F of the Annual Report on Form 20-F dated March 31 , 2025 of IM Cannabis Corp. and are in agreement with the statements contained in the first to fifth paragraphs in Item 16F therein. We have no basis to agree or disagree with other statements of the registrant |
|
| March 31, 2025 |
CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 12.1 CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 I, Oren Shuster, certify that: 1. I have reviewed this annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the ci |
|
| March 31, 2025 |
Re: Cancellation of License Agreement Dated April 2, 2019 Exhibit 4.2 February 26, 2024 To: Focus Medical Herbs Ltd. Beit Hakshatot, Glil Yam, Israel Re: Cancellation of License Agreement Dated April 2, 2019 This letter serves as formal notification that IMC Holdings Ltd. has ceased charging Focus Medical Herbs Ltd. for royalties as of February 26, 2024. Accordingly, we hereby cancel the License Agreement dated April 2, 2019, between IMC Holdings Ltd. an |
|
| March 31, 2025 |
Exhibit 4.6 AGREEMENT THIS AGREEMENT (the “Agreement”) is entered into as of the 26 day of May 2024 (the “Effective Date”), by and among IM Cannabis Corp (“Company” or “IMCC”), I.M.C Holdings Ltd. (“Holding Company”), and Kadimastem Ltd. (“Kadimastem”) (each of the parties above – a “Party” and, collectively, the “Parties”). WHEREAS, on February 13, 2024, the Kadimastem and Company entered into a |
|
| March 31, 2025 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of IM Cannabis Corp. (the "Company") on Form 20-F for the period ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Oren Shuster, Chief Executive Officer of the Company, cert |
|
| March 31, 2025 |
Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of IM Cannabis Corp. (the "Company") on Form 20-F for the period ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Uri Birenberg, Chief Financial Officer of the Company, cer |
|
| March 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| March 20, 2025 |
Exhibit 99.1 IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET TORONTO and GLIL YAM, Israel, March 20, 2025/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth qu |
|
| March 5, 2025 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 02/28/2025: 3,085,452 Common Shares Date: March 5, 2025 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Whe |
|
| March 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| February 5, 2025 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 01/31/2025: 3,085,452 Common Shares Date: February 5, 2025 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. |
|
| February 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| January 17, 2025 |
IM Cannabis Announces Change of Auditors Exhibit 99.1 IM Cannabis Announces Change of Auditors TORONTO and GLIL YAM, Israel, January 17, 2025 - IM Cannabis Corp. (“IMC” or the “Company”) (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, announces that it has changed its auditor from Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global (the “Predecessor Auditor”) to Fahn Kanne |
|
| January 17, 2025 |
Exhibit 99.4 Kost Forer Gabbay & Kasierer 144 Menachem Begin Road, Building A Tel-Aviv 6492102, Israel Tel: +972-3-6232525 Fax: +972-3-5622555 ey.com January 17, 2025 Canadian Securities Exchange British Columbia Securities Commission Alberta Securities Commission Ontario Securities Commission Financial And Consumer Services Commission (New Brunswick) Manitoba Securities Commission Nova Scotia Sec |
|
| January 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| January 17, 2025 |
Exhibit 99.3 January 16, 2025 Fahn Kanne & Co. Head Office 32 Hamasger Street Tel-Aviv 6721118, ISRAEL PO Box 36172, 6136101 T +972 3 7106666 F +972 3 7106660 www.gtfk.co.il To: Canadian Securities Exchange British Columbia Securities Commission Alberta Securities Commission Ontario Securities Commission Financial And Consumer Services Commission (New Brunswick) Manitoba Securities Commission Nova |
|
| January 17, 2025 |
IM CANNABIS CORP. NOTICE OF CHANGE OF AUDITOR Exhibit 99.2 IM CANNABIS CORP. NOTICE OF CHANGE OF AUDITOR To: Fahn Kanne & Co. Grant Thornton Israel And To: Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global And To: Canadian Securities Exchange British Columbia Securities Commission Alberta Securities Commission Ontario Securities Commission Financial And Consumer Services Commission (New Brunswick) Manitoba Securities Commission N |
|
| January 6, 2025 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 12/31/2024: 3,085,452 Common Shares Date: January 6, 2025 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. W |
|
| January 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| December 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| December 4, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 11/30/2024: 3,085,452 Common Shares Date: December 4, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. |
|
| November 14, 2024 |
IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of September 30, 2024 Exhibit 99.2 IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of September 30, 2024 (Unaudited) INDEX Page Interim Condensed Consolidated Statements of Financial Position 2 - 3 Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income 4 - 5 Interim Condensed Consolidated Statements of Changes in Equity 6 Interim Condensed Consolidated Statem |
|
| November 14, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended September 30, 2024. 2. No misrepresentations: Based on my kno |
|
| November 14, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Uri Birenberg, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended September 30, 2024. 2. No misrepresentations: Based on my kn |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION 6-K 1 zk2432281.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 |
|
| November 14, 2024 |
Exhibit 99.1 IM Cannabis Reports Third Quarter Financial Results IMC pairs a +12% increase in revenue with a -16% decrease in the total operating expenses, building a solid foundation to deliver in 2025. TORONTO, and GLIL YAM, Israel, November 14, 2024 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its fina |
|
| November 14, 2024 |
Exhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 6 GEOGRAPHIES AND NEW MARKETS 6 BRANDS 7 NEW PRODUCT OFFERINGS 11 HIGH-QUALITY, RELIABLE SUPPLY 12 CORPORATE HIGHLIGHTS AND EVENTS 12 REVIEW OF FINANCIAL PERFORMANCE 18 LEGAL AND REGULATORY 51 RISK FACTORS 61 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 67 2 Management’s Discussion an |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| November 6, 2024 |
IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET Exhibit 99.1 IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET TORONTO and GLIL YAM, Israel, November 6, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third 2024 ended Sep |
|
| November 5, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 10/31/2024: 2,232,359 Common Shares Date: November 5, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. |
|
| November 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| October 4, 2024 |
DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Exhibit 99.1 THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management Toronto, Ontario and Glil Yam, Israel – October 4, 2024 – IM Cannabis Corp. (“IM Cannabis” or the “Company”) (NASDAQ: IMCC) (CSE: |
|
| October 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| October 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| October 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal e |
|
| October 2, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 9/30/2024: 2,232,359 Common Shares Date: October 2, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Wh |
|
| October 2, 2024 |
IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2 Exhibit 99.1 IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2 TORONTO, GLIL YAM, Israel – October 2, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that the preliminary sales results in Germany by its German su |
|
| September 19, 2024 |
CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 12.2 CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 I, Uri Birenberg, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements |
|
| September 19, 2024 |
CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 12.1 CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 I, Oren Shuster, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements m |
|
| September 19, 2024 |
IM CANNABIS CORP. INCENTIVE COMPENSATION RECOVERY POLICY Exhibit 97 IM CANNABIS CORP. INCENTIVE COMPENSATION RECOVERY POLICY 1. Introduction. The Board of Directors of IM Cannabis Corp. (the “Company”) believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company's compensation philosophy. The Board has therefore adopted this pol |
|
| September 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 1) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC |
|
| September 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal e |
|
| September 11, 2024 |
IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors Exhibit 99.1 IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors TORONTO and GLIL YAM, Israel, September 11, 2024 - IM Cannabis Corp. (“IMC” or the “Company”) (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Mr. Shmulik Arbel has been appointed to the Company’s board of directors (the “Board”) eff |
|
| September 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| September 9, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 8/31/2024: 2,232,359 Common Shares Date: September 9, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. |
|
| August 14, 2024 |
Exhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 6 GEOGRAPHIES AND NEW MARKETS 6 BRANDS 8 NEW PRODUCT OFFERINGS 12 HIGH-QUALITY, RELIABLE SUPPLY 12 CORPORATE HIGHLIGHTS AND EVENTS 12 REVIEW OF FINANCIAL PERFORMANCE 18 LEGAL AND REGULATORY 46 RISK FACTORS 55 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 61 2 Management’s Discussion an |
|
| August 14, 2024 |
Exhibit 99.1 IM Cannabis Reports Second Quarter Financial Results IMC Germany delivers +200% in sales in first three months after German legalization, while overall revenue grows 12% vs Q2 2023 TORONTO, and GLIL YAM, Israel, August 14, 2024 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial result |
|
| August 14, 2024 |
Exhibit 99.2 IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2024 Canadian dollars in thousands (Unaudited) INDEX Page Interim Condensed Consolidated Statements of Financial Position F-2 - F-3 Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income F-4 - F-5 Interim Condensed Consolidated Statements of Changes in Equity F-6 In |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| August 14, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Uri Birenberg, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended June 30, 2024. 2. No misrepresentations: Based on my knowled |
|
| August 14, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended June 30, 2024. 2. No misrepresentations: Based on my knowle |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| August 6, 2024 |
IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14 Exhibit 99.1 IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET TORONTO and GLIL YAM, Israel, August 6, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter 2024 en |
|
| August 6, 2024 |
6-K 1 zk2431771.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Add |
|
| August 6, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 7/31/2024: 2,232,359 Common Shares Date: August 6, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Whe |
|
| July 29, 2024 |
Exhibit 99.1 IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement TORONTO and GLIL YAM, Israel, July 29, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced that on July 26, 2024, it has received formal notic |
|
| July 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| July 12, 2024 |
IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis Exhibit 99.1 IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis TORONTO and GLIL YAM, Israel, July 12, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IM Cannabis”), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further to its press release dated July 5, 2024, effective today the Company’s common shares |
|
| July 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| July 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| July 5, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 6/30/2024: 13,394,136 Common Shares Date: July 5, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Wher |
|
| July 5, 2024 |
IM Cannabis Announces Intention to Complete Consolidation Exhibit 99.1 IM Cannabis Announces Intention to Complete Consolidation TORONTO and GLIL YAM, Israel, July 5, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company”, “IM Cannabis”, or “IMC”), a leading medical cannabis company with operations in Israel and Germany, announces that the board of directors of the Company (the “Board”) has approved a consolidation of its issued and outs |
|
| July 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| June 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| June 6, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 5/31/2024: 13,394,136 Common Shares Date: June 6, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Wher |
|
| June 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| June 5, 2024 |
Exhibit 99.1 IMCC Addresses Accelerated Growth in Germany Through new Supply Agreement with EU-GMP Certified Glasshouse Botanics and Announces a Change to its Board of Directors IMC Germany’s accelerated growth potential leans strongly on its supply strategy through its ability to partner with cannabis growers for EU-GMP certification, bolstering the company’s supply chain with exclusive product. |
|
| May 29, 2024 |
IM Cannabis Closes Convertible Debenture Offering to Support Accelerated Growth in Germany Exhibit 99.1 IM Cannabis Closes Convertible Debenture Offering to Support Accelerated Growth in Germany Through continuous, active cost management, IMC reduced its annual G&A costs by 49% in 2023 and is now looking to significantly reduce its financial costs. TORONTO and GLIL YAM, Israel, May 29, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company”, “IM Cannabis”, or “IMC”), a l |
|
| May 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 8, 2024 |
Exhibit 99.2 IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of March 31, 2024 Canadian dollars in thousands (Unaudited) INDEX Page Interim Condensed Consolidated Statements of Financial Position 2 - 3 Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income 4 - 5 Interim Condensed Consolidated Statements of Changes in Equity 6 Interim Con |
|
| May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 8, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Uri Birenberg, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended March 31, 2024. 2. No misrepresentations: Based on my knowle |
|
| May 8, 2024 |
Exhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 6 GEOGRAPHIES AND NEW MARKETS 6 BRANDS 8 NEW PRODUCT OFFERINGS 12 HIGH-QUALITY, RELIABLE SUPPLY 12 CORPORATE HIGHLIGHTS AND EVENTS 13 REVIEW OF FINANCIAL PERFORMANCE 18 LEGAL AND REGULATORY 44 RISK FACTORS 53 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 59 2 Management’s Discussion an |
|
| May 8, 2024 |
Exhibit 99.1 IM Cannabis Reports First Quarter Financial Results IMC prepares for accelerated growth after legalization in Germany and recovers from the impact of the Israel-Hamas war. TORONTO, and GLIL YAM, Israel, May 8, 2024 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for t |
|
| May 8, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended March 31, 2024. 2. No misrepresentations: Based on my knowl |
|
| May 6, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 4/30/2024: 13,394,136 Common Shares Date: May 6, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was i |
|
| May 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| May 1, 2024 |
IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8 Exhibit 99.1 IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9:00am ET TORONTO and GLIL YAM, Israel, May 1, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2024 ended March |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| April 16, 2024 |
IMC to transfer its Oranim Pharmacy shares back to the seller Exhibit 99.1 IMC to transfer its Oranim Pharmacy shares back to the seller TORONTO and GLIL YAM, Israel, April 16, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installmen |
|
| April 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| April 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| April 9, 2024 |
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market Exhibit 99.1 IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market TORONTO and GLIL YAM, Israel, April 9, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, entered, through its subsidiary, a strategic distribution agreement with Vessel |
|
| April 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| April 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| April 4, 2024 |
Avant and IMC Execute BLK MKTTM Trademark Licensing Agreement for the German Medical Cannabis Market Exhibit 99.1 Avant and IMC Execute BLK MKTTM Trademark Licensing Agreement for the German Medical Cannabis Market TORONTO, GLIL YAM, Israel and KELOWNA B.C. - April 4, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, and Avant Brands Inc. (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BU0) |
|
| April 4, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 3/31/2024: 13,394,136 Common Shares Date: April 4, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| April 1, 2024 |
Exhibit 99.1 IMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients. With the implementation of the anticipated medical cannabis regulatory reform, the Israeli ministry of health removed many of the heavy regulations in the sector, making medical cannabis more accessible to new patients. TORONTO and GLIL YAM, Israel, April 1, 202 |
|
| March 28, 2024 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of IM Cannabis Corp. (the "Company") on Form 20-F for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Oren Shuster, Chief Executive Officer of the Company, cert |
|
| March 28, 2024 |
CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 12.2 CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 I, Uri Birenberg, certify that: 1. I have reviewed this annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the c |
|
| March 28, 2024 |
Consent of Independent Registered Public Accounting Firm EXHIBIT 15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form F-10 No. 333-254255) of IM Cannabis Corp. and in the related Prospectus of our report dated March 28, 2024, with respect to the consolidated financial statements of IM Cannabis Corp. included in this Annual Report (Form 20-F) for the year ended Dece |
|
| March 28, 2024 |
Exhibit 4.5 LOAN AGREEMENT THIS LOAN AGREEMENT (this “Loan Agreement”, or the “Agreement”) is made and entered this February 28, 2024 (the “Effective Date”), by and between I.M.C Holdings Ltd., an Israeli limited liability company, of Beit HaKshatot, Glil Yam, Israel 4690500 (the “Company” or “Borrower”) and Kadimastem Ltd., an Israeli limited liability company, of Pinchas Sapir 7, Weizmann Scienc |
|
| March 28, 2024 |
Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of IM Cannabis Corp. (the "Company") on Form 20-F for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Uri Birenberg, Chief Financial Officer of the Company, cer |
|
| March 28, 2024 |
IM CANNABIS CORP. STOCK TRADING POLICY Exhibit 11.1 IM CANNABIS CORP. STOCK TRADING POLICY IM CANNABIS CORP. STOCK TRADING POLICY 1. Purpose of this Policy The board of directors (the “Board”) of IM Cannabis Corp. (the “Company”) has adopted this Stock Trading Policy (the “Policy”), which is designed to provide guidance to the directors, officers and employees of the Company and its subsidiaries (who are referred to collectively in thi |
|
| March 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT |
|
| March 28, 2024 |
Exhibit 15.2 TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 6 GEOGRAPHIES AND NEW MARKETS 6 BRANDS 8 NEW PRODUCT OFFERINGS 12 HIGH-QUALITY, RELIABLE SUPPLY 13 CORPORATE HIGHLIGHTS AND EVENTS 13 REVIEW OF FINANCIAL PERFORMANCE 25 LEGAL AND REGULATORY 54 RISK FACTORS 62 CAUTION CONCERNING FORWARD-LOOKING INFORMATION 67 2 INTRODUCTION IM Cannabis Corp. (“IM Cannabis” or the “Company”) is a |
|
| March 28, 2024 |
CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 12.1 CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 I, Oren Shuster, certify that: 1. I have reviewed this annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the ci |
|
| March 25, 2024 |
IMC Welcomes the Groundbreaking Cannabis Legalization in Germany Exhibit 99.1 IMC Welcomes the Groundbreaking Cannabis Legalization in Germany By rescheduling medical cannabis, from a narcotic to a regular prescription, the German medical cannabis market is expected to deliver strong growth, providing IMC Germany with a unique opportunity to further accelerate growth in 2024 after delivering 180% growth in 2023. TORONTO and GLIL YAM, Israel, March 25, 2024/CNW/ |
|
| March 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| March 20, 2024 |
Exhibit 99.1 IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ET TORONTO and GLIL YAM, Israel, March 20, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth quart |
|
| March 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| March 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| March 6, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 2/29/2024: 13,394,136 Common Shares Date: March 6, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was |
|
| February 28, 2024 |
Exhibit 99.1 Not for distribution to United States newswire services or for dissemination in the United States IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company. TORONTO and GLIL YAM, Israel, February 28, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Ge |
|
| February 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| February 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| February 7, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 1/31/2024: 13,394,136 Common Shares Date: February 7, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer |
|
| January 31, 2024 |
Exhibit 99.1 IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price Rule TORONTO and GLIL YAM, Israel, January 31, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, announced today that it has received a 180 calendar day |
|
| January 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| January 12, 2024 |
IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition Exhibit 99.1 IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition TORONTO and GLIL YAM, Israel, January 12, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that the final sixth payment of the Oranim Pharmacy Acquisition and the reconciliation between the partie |
|
| January 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| January 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| January 4, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 12/31/2023: 13,394,136 Common Shares Date: January 4, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer |
|
| January 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| January 2, 2024 |
IMC Announces the Conclusion of the Planning and Construction Legal Proceedings Exhibit 99.1 IMC Announces the Conclusion of the Planning and Construction Legal Proceedings TORONTO and GLIL YAM, Israel, January 2, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that the construction proceedings against Focus Medical Herbs Ltd. ("Focus Medical"), were conc |
|
| December 8, 2023 |
Exhibit 99.1 New Israeli cannabis regulation, facilitating access for many new patients, scheduled for December 29, 2023, has been postponed by three months; Israeli Ministry of Health published a new report showing a surge in new medical cannabis patients in November 2023. TORONTO and GLIL YAM, Israel, December 8, 2023/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), |
|
| December 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| December 7, 2023 |
Exhibit 99.1 IM CANNABIS CORP. (THE “COMPANY”) REPORT OF VOTING RESULTS Section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations This report describes the matters voted upon and the outcome of the annual general meeting of shareholders of the Company held at the offices of the Company’s legal counsel, Garfinkle Biderman LLP, located at 1 Adelaide Street East, Suite 801, Toron |
|
| December 7, 2023 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 30/11/2023: 13,394,136 Common Shares Date: December 7, 2023 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer |
|
| December 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| December 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| November 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| November 27, 2023 |
IM Cannabis Announces Receipt of Court Action Exhibit 99.1 IM Cannabis Announces Receipt of Court Action Toronto, Ontario and Glil Yam, Israel, November 27, 2023/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC”), a leading medical cannabis company with operations in Israel and Germany announces that a complaint was in the Ontario Superior Court of Justice in Canada by Michael Wiener, 35 Oak Holdings Ltd. and MW Inve |
|
| November 13, 2023 |
Exhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 5 GEOGRAPHIES AND NEW MARKETS 5 BRANDS 7 NEW PRODUCTS OFFERINGS 11 HIGH-QUALITY, RELIABLE SUPPLY 11 REVIEW OF FINANCIAL PERFORMANCE 16 LEGAL AND REGULATORY 40 RISK FACTORS 47 CAUTION CONCERNING FORWARD-LOOKING INFORMATION 52 2 Management’s Discussion and Analysis INTRODUCTION IM Cannabis Corp |
|
| November 13, 2023 |
Exhibit 99.2 NOTICE TO READER The accompanying unaudited condensed interim consolidated financial statements of IM Cannabis Corp. (the “Company”) have been prepared by and are the responsibility of management. The unaudited condensed interim consolidated financial statements have not been reviewed by the Company's auditors. F - 2 IM CANNABIS CORP. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATE |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| November 13, 2023 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended September 30, 2023. 2. No misrepresentations: Based on my kno |
|
| November 13, 2023 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Itay Vago, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended September 30, 2023. 2. No misrepresentations: Based on my knowle |
|
| November 13, 2023 |
IM Cannabis Reports Third Quarter 2023 Financial Results Exhibit 99.1 IM Cannabis Reports Third Quarter 2023 Financial Results IMC remains singularly focused on accelerating its path to profitability through active cost management and margin improvement while maintaining sales. TORONTO, and GLIL YAM, Israel, Nov. 13, 2023 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, anno |
|
| November 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| November 9, 2023 |
FORM 51-102F3 MATERIAL CHANGE REPORT Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Company IM Cannabis Corp. (the “Company”) Kibbutz Glil Yam Central District 4690500 Israel Item 2: Date of Material Change October 3, 10 and 11, 2023. Item 3: News Release A news release was issued by the Company via Newswire on October 13, 2023, and filed on SEDAR+ at www.sedarplus.ca. Item 4: Summary of Material Change |
|
| November 8, 2023 |
IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ET Exhibit 99.1 IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ET TORONTO and GLIL YAM, Israel, Nov 8, 2023/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter ended Septembe |
|
| November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| November 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| November 6, 2023 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 31/10/2023: 13,394,136 Common Shares Date: November 6, 2023 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer |
|
| October 31, 2023 |
IM CANNABIS CORP. NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS Exhibit 99.2 IM CANNABIS CORP. NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that the annual general meeting (the “Meeting”) of the holders of common shares of IM Cannabis Corp. (the “Company”) will be held at the offices of the Company’s legal counsel, Garfinkle Biderman LLP, located at 1 Adelaide Street East, Suite 801, Toronto, Ontario M5C 2V9 on Wednesday, December 6, |
|
| October 31, 2023 |
Proxies submitted must be received by 10:00 a.m., Toronto Time on December 4, 2023. Exhibit 99.4 Security Class Holder Account Number - Fold Form of Proxy - Annual General Meeting to be held on December 6, 2023 Form of Proxy - Annual General Meeting to be held on December 6, 2023 This Form of Proxy is solicited by and on behalf of Management. Notes to proxy 1. Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to attend a |
|
| October 31, 2023 |
Exhibit 99.6 ☐ Interim Financial Statements Mark this box if you would like to receive Interim Financial Statements by mail. ☐ Annual Financial Statements Mark this box if you would like to receive the Annual Financial Statements by mail. Financial Statements Request Form Under securities regulations, a reporting issuer must send annually a form to holders to request the Interim Financial Statemen |
|
| October 31, 2023 |
Exhibit 99.5 ■ 1 1 P99525- E 1 OF 1 VOTING INSTRUCTION FORM IM CANNABIS CORP. MEETING TYPE: ANNUAL MEETING MEETING DATE: WEDNESDAY, DECEMBER 06, 2023 AT 10:00 A.M. EST RECORD DATE: FOR HOLDERS AS OF OCTOBER 19, 2023 PROXY DEPOSIT DATE: DECEMBER 04, 2023 CUID: ACCOUNT NO: CUSIP: 44969Q307 CONTROL NO.: STEP 2 APPOINT A PROXY (OPTIONAL) APPOINTEE(S): Oren Shuster, Shimmy Posen, Adam Fishman IF YOU WI |
|
| October 31, 2023 |
Exhibit 99.7 IM CANNABIS CORP. CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2022 AUDITED IM CANNABIS CORP. CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2022 CANADIAN DOLLARS IN THOUSANDS INDEX Page Report of Independent Registered Public Accounting Firm (PCAOB ID: 1281) F-2 Consolidated Statements of Financial Position F-3 – F-4 Consolidated Statements of Profit or Loss and Other C |
|
| October 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| October 31, 2023 |
Exhibit 99.8 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 6 GEOGRAPHIES AND NEW MARKETS 6 BRANDS 8 NEW PRODUCT OFFERINGS 10 HIGH-QUALITY, RELIABLE SUPPLY 11 CORPORATE HIGHLIGHTS AND EVENTS 12 REVIEW OF FINANCIAL PERFORMANCE 20 LEGAL AND REGULATORY 49 RISK FACTORS 55 CAUTION CONCERNING FORWARD-LOOKING INFORMATION 60 2 INTRODUCTION IM Cannabis Corp. ( |
|
| October 31, 2023 |
NOTICE-AND-ACCESS NOTIFICATION TO BENEFICIAL SHAREHOLDERS OF IM CANNABIS CORP. Exhibit 99.1 NOTICE-AND-ACCESS NOTIFICATION TO BENEFICIAL SHAREHOLDERS OF IM CANNABIS CORP. You are receiving this notification because IM Cannabis Corp. (the “Company”) has elected to use the “notice-and-access” mechanism provided for under National Instrument 54-101 – Communication with Beneficial Owners of Securities of a Reporting Issuer to deliver to holders of common shares in the capital of |
|
| October 31, 2023 |
IM CANNABIS CORP. MANAGEMENT INFORMATION CIRCULAR SOLICITATION OF PROXIES Exhibit 99.3 IM CANNABIS CORP. MANAGEMENT INFORMATION CIRCULAR SOLICITATION OF PROXIES This management information circular (this “Circular”) is furnished in connection with the solicitation, by or on behalf of the management (“Management”) of IM Cannabis Corp. (the “Company”), of proxies to be used at the Company’s annual general meeting (the “Meeting”) of the holders of common shares of the Comp |
|
| October 13, 2023 |
Exhibit 99.1 IM Cannabis Releases a Message from the CEO about the Israel-Hamas War and announces securing C$1,390,000 in Short-Term Debt Toronto, Ontario and Glil Yam, Israel, October 13, 2023/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC”), a leading medical cannabis company with operations in Israel and Germany releases message from Chief Executive Officer about the |
|
| October 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| October 10, 2023 |
IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial Officer Exhibit 99.1 IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial Officer TORONTO and GLIL YAM, Israel, October 10, 2023/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Uri Birenberg will join the company’s leadership team as Chief |
|
| October 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| October 3, 2023 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 30/9/2023: 13,394,136 Common Shares Date: October 3, 2023 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer w |
|
| October 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| September 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal e |
|
| September 29, 2023 |
FORM 51-102F3 MATERIAL CHANGE REPORT Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Company IM Cannabis Corp. (the “Company”) Kibbutz Glil Yam Central District 4690500 Israel Item 2: Date of Material Change September 19, 2023. Item 3: News Release A news release was issued by the Company via Newswire on September 19, 2023, and filed on SEDAR+ at www.sedarplus.ca, a copy of which is attached hereto as Sc |
|
| September 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| September 19, 2023 |
IM Cannabis Announces CFO Departure Exhibit 99.1 IM Cannabis Announces CFO Departure Toronto, Ontario and GLIL YAM, Israel, September 19, 2023/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading international medical cannabis company with operations in Israel and Germany, today announced that Itay Vago, the Company's Chief Financial Officer, has decided to leave the Company for pers |
|
| September 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal e |
|
| September 5, 2023 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 31/8/2023: 13,394,136 Common Shares Date: September 5, 2023 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer |
|
| August 14, 2023 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Itay Vago, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended June 30, 2023. 2. No misrepresentations: Based on my knowledge, |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| August 14, 2023 |
Exhibit 99.2 NOTICE TO READER The accompanying unaudited condensed interim consolidated financial statements of IM Cannabis Corp. (the “Company”) have been prepared by and are the responsibility of management. The unaudited condensed interim consolidated financial statements have not been reviewed by the Company's auditors. F - 2 IM CANNABIS CORP. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATE |
|
| August 14, 2023 |
Exhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 6 GEOGRAPHIES AND NEW MARKETS 6 BRANDS 8 NEW PRODUCT OFFERINGS 11 HIGH-QUALITY, RELIABLE SUPPLY 11 REVIEW OF FINANCIAL PERFORMANCE 15 LEGAL AND REGULATORY 40 RISK FACTORS 47 CAUTION CONCERNING FORWARD-LOOKING INFORMATION 52 2 Management’s Discussion and Analysis INTRODUCTION IM Cannabis Corp. |
|
| August 14, 2023 |
IM Cannabis Reports Second Quarter 2023 Financial Results Exhibit 99.1 IM Cannabis Reports Second Quarter 2023 Financial Results IMC remains singularly focused on accelerating the path to profitability through active cost management and margin improvement while maintaining sales. TORONTO, and GLIL YAM, Israel, Aug. 11, 2023 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, ann |
|
| August 14, 2023 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended June 30, 2023. 2. No misrepresentations: Based on my knowledg |
|
| August 14, 2023 |
FORM 5 QUARTERLY LISTING STATEMENT Exhibit 99.6 FORM 5 QUARTERLY LISTING STATEMENT Name of Listed Issuer: IM Cannabis Corp (the “Issuer”). Trading Symbol: IMCC This Quarterly Listing Statement must be posted on or before the day on which the Issuer’s unaudited interim financial statements are to be filed under the Securities Act, or, if no interim statements are required to be filed for the quarter, within 60 days of the end of the |
|
| August 11, 2023 |
Exhibit 99.1 IMC welcomes new Israeli cannabis regulations which are about to change significantly, facilitating access for many new patients The Israeli ministry of health announced the anticipated medical cannabis regulatory reform on Monday August 7, 2023. The new regulations will remove many of the heavy regulations in the sector, making medical cannabis more accessible to patients as well as |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| August 8, 2023 |
IM Cannabis to Report Second Quarter 2023 Financial Results on Monday, August 14 at 9:00am ET Exhibit 99.1 IM Cannabis to Report Second Quarter 2023 Financial Results on Monday, August 14 at 9:00am ET TORONTO and GLIL YAM, Israel, Aug 8, 2023/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter ended June 30, |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| August 4, 2023 |
IM Cannabis Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency Exhibit 99.1 IM Cannabis Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency TORONTO and GLIL YAM, Israel, August 4, 2023/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, announced today that the Company received written notification (the "Notification Letter") from |
|
| August 2, 2023 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 31/7/2023: 13,394,136 Common Shares Date: August 2, 2023 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer wa |
|
| August 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| July 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| July 6, 2023 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 30/6/2023: 13,389,551 Common Shares Date: July 6, 2023 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was |
|
| June 13, 2023 |
Exhibit 99.1 IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement TORONTO and GLIL YAM, Israel, June 13, 2023/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced that on June 12, 2023, it has received formal notic |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| June 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| June 6, 2023 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 31/5/2023: 13,389,551 Common Shares Date: June 6, 2023 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was |
|
| May 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 30, 2023 |
FORM 11 NOTICE OF PROPOSED STOCK OPTION GRANT OR AMENDMENT Exhibit 99.1 FORM 11 NOTICE OF PROPOSED STOCK OPTION GRANT OR AMENDMENT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer”). Trading Symbol: IMCC Date: May 30, 2023 1. New Options Granted: Date of Grant: May 16, 2023 Position (Director/ Officer/ No. of Employee/ Options Consultant/ Insider No. of Granted in Management Yes or Optioned Exercise Expiry Past 12 Name of Optionee Company No? Shares |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 19, 2023 |
IM CANNABIS CORP. STATEMENT OF EXECUTIVE COMPENSATION DATED MAY 19, 2023 Exhibit 99.1 IM CANNABIS CORP. STATEMENT OF EXECUTIVE COMPENSATION DATED MAY 19, 2023 The following information is presented in accordance with National Instrument 51-102 – Continuous Disclosure Obligations ("NI 51-102") and Form 51-102F6 – Statement of Executive Compensation ("Form 51-102F6"), and sets forth compensation for each Named Executive Officer (as defined below) and director of IM Canna |
